Berberine suppresses adipocyte differentiation via decreasing CREB transcriptional activity

PLoS ONE

Volumn 10, Issue 4, 2015, Pages

  Zhang, Juan ^a   Tang, Hongju ^a   Deng, Ruyuan ^a   Wang, Ning ^a   Zhang, Yuqing ^a   Wang, Yao ^a   Liu, Yun ^a   Li, Fengying ^a   Wang, Xiao ^a   Zhou, Libin ^a  

^a SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

Author keywords

[No Author keywords available]

Indexed keywords

BERBERINE; CCAAT ENHANCER BINDING PROTEIN ALPHA; CCAAT ENHANCER BINDING PROTEIN BETA; CRE RECOMBINASE; CYCLIC AMP RESPONSIVE ELEMENT BINDING PROTEIN; FORSKOLIN; ISOBUTYLMETHYLXANTHINE; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA 2;

3T3 CELL LINE; ADIPOCYTE; ADIPOGENESIS; ADIPOGENIC GENE; ANIMAL CELL; ARTICLE; CELL DIFFERENTIATION; CONTROLLED STUDY; DEVELOPMENTAL STAGE; DRUG MECHANISM; ENZYME ACTIVITY; ENZYME BINDING; GENE; GENE EXPRESSION REGULATION; MOUSE; NONHUMAN; PROADIPOCYTE; PROMOTER REGION; PROTEIN BINDING; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; ANIMAL; CHROMATIN IMMUNOPRECIPITATION; DRUG EFFECTS; METABOLISM; PHOSPHORYLATION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; WESTERN BLOTTING;

3T3-L1 CELLS; ADIPOCYTES; ANIMALS; BERBERINE; BLOTTING, WESTERN; CELL DIFFERENTIATION; CHROMATIN IMMUNOPRECIPITATION; CYCLIC AMP RESPONSE ELEMENT-BINDING PROTEIN; MICE; PHOSPHORYLATION; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION;

EID: 84946063710     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0125667     Document Type: Article

References (38)

1. Kopelman PG. Obesity as a medical problem. Nature. 2000;404:635-643. PMID: 10766250
2. Bae KW, Kim WK, Lee SC. Involvement of protein tyrosine phosphatases in adipogenesis: New antiobesity targets? BMB Reports. 2012;45:700-706. PMID: 23261055
3. Poulos SP, Dodson MV, Hausman GJ. Cell line models for differentiation: preadipocytes and adipocytes. Exp Biol Med. 2010;235:1185-1193. doi: 10.1258/ebm.2010.010063 PMID: 20864461
4. Stephens JM. The fat controller: adipocyte development. PLoS Biol. 2012;10:e1001436. doi: 10.1371/journal.pbio.1001436 PMID: 23209380
5. Petersen RK, Madsen L, Pedersen LM, Hallenborg P, Hagland H, Viste K, et al. Cyclic AMP (cAMP) - mediated stimulation of adipocyte differentiation requires the synergistic action of Epac- and cAMP-dependent protein kinase-dependent processes. Mol Cell Biol. 2008;28:3804-3816. doi: 10.1128/MCB. 00709-07 PMID: 18391018
6. Zhang Y, Li X, Zou D, Liu W, Yang J, Zhu N, et al. Treatment of type 2 diabetes and dyslipidemia with the natural plant alkaloid berberine. J Clin Endocrinol Metab. 2008;93:2559-2565. doi: 10.1210/jc. 2007-2404 PMID: 18397984
7. Lee YS, Kim WS, Kim KH, Yoon MJ, Cho HJ, Shen Y, et al. Berberine, a natural plant product, activates AMP-activated protein kinase with beneficial metabolic effects in diabetic and insulin-resistant states. Diabetes. 2006;55:2256-2264 PMID: 16873688
8. Zhou L, Wang X, Shao L, Yang Y, Shang W, Yuan G, et al. Berberine acutely inhibits insulin secretion from beta-cells through 3', 5'-cyclic adenosine 5'-monophosphate signaling pathway. Endocrinology. 2008;149:4510-4518. doi: 10.1210/en. 2007-1752 PMID: 18511510
9. Pham TP, Kwon J, Shin J. Berberine exerts anti-adipogenic activity through up-regulation of C/EBP inhibitors, CHOP and DEC2. Biochem Biophys Res Commun. 2011;413:376-382. doi: 10.1016/j.bbrc. 2011.08.110 PMID: 21893041
10. Hu Y, Kutscher E, Davies GE. Berberine inhibits SREBP-1-related clozapine and risperidone induced adipogenesis in 3T3-L1 cells. Phytother Res. 2010;24:1831-1838. doi: 10.1002/ptr.3204 PMID: 20564506
11. Ikarashi N, Tajima M, Suzuki K, Toda T, Ito K, Ochiai W, et al. Inhibition of preadipocyte differentiation and lipid accumulation by Orengedokuto treatment of 3T3-L1 cultures. Phytother Res. 2012;26:91-100. doi: 10.1002/ptr.3493 PMID: 21557367
12. Zhang Z, Zhang H, Li B, Meng X, Wang J, Zhang Y, et al. Berberine activates thermogenesis in white and brown adipose tissue. Nat Commun. 2014;5:5493. doi: 10.1038/ncomms6493 PMID: 25423280
13. Turner N, Li JY, Gosby A, To SW, Cheng Z, Miyoshi H, et al. Berberine and its more biologically available derivative, dihydroberberine, inhibit mitochondrial respiratory complex I: a mechanism for the action of berberine to activate AMP-activated protein kinase and improve insulin action. Diabetes. 2008;57:1414-1418. doi: 10.2337/db07-1552 PMID: 18285556
14. Brusq JM, Ancellin N, Grondin P, Guillard R, Martin S, Saintillan Y, et al. Inhibition of lipid synthesis through activation of AMP kinase: an additional mechanism for the hypolipidemic effects of berberine. J Lipid Res. 2006;47:1281-1288. PMID: 16508037
15. Zhou L, Wang X, Yang Y, Wu L, Li F, Zhang R, et al. Berberine attenuates cAMP-induced lipolysis via reducing the inhibition of phosphodiesterase in 3T3-L1 adipocytes. Biochim Biophys Acta. 2011;1812:527-535. doi: 10.1016/j.bbadis.2010.10.001 PMID: 20969954
16. Vingtdeux V, Chandakkar P, Zhao H, Davies P, Marambaud P. Small-molecule activators of AMP-activated protein kinase (AMPK), RSVA314 and RSVA405, inhibit adipogenesis. Mol Med. 2011;17:1022-1030. doi: 10.2119/molmed.2011.00163 PMID: 21647536
17. Ono M, Fujimori K. Antiadipogenic effect of dietary apigenin through activation of AMPK in 3T3-L1 cells. J Agric Food Chem. 2011;59:13346-13352. doi: 10.1021/jf203490a PMID: 22098587
18. Kim EJ, Lee DH, Kim HJ, Lee SJ, Ban JO, Cho MC, et al. Thiacremonone, a sulfur compound isolated from garlic, attenuates lipid accumulation partially mediated via AMPK activation in 3T3-L1 adipocytes. J Nutr Biochem. 2012;23:1552-1558. doi: 10.1016/j.jnutbio.2011.10.008 PMID: 22405697
19. Hwang JT, Kim SH, Lee MS, Kim SH, Yang HJ, Kim MJ, et al. Anti-obesity effects of ginsenoside Rh2 are associated with the activation of AMPK signaling pathway in 3T3-L1 adipocyte. Biochem Biophys Res Commun. 2007;364:1002-1008. PMID: 17971295
20. Zhou L, Yang Y, Wang X, Liu S, Shang W, Yuan G, et al. Berberine stimulates glucose transport through a mechanism distinct from insulin. Metabolism. 2007;56:405-412. PMID: 17292731
21. Nam M, Lee WH, Bae EJ, Kim SG. Compound C inhibits clonal expansion of preadipocytes by increasing p21 level irrespectively of AMPK inhibition. Arch Biochem Biophys. 2008;479:74-81. doi: 10. 1016/j.abb.2008.07.029 PMID: 18721791
22. Zhang JW, Klemm DJ, Vinson C, Lane MD. Role of CREB in transcriptional regulation of CCAAT/enhancerbinding protein beta gene during adipogenesis. J Biol Chem. 2004;279:4471-4478. PMID: 14593102
23. Belmonte N, Phillips BW, Massiera F, Villageois P, Wdziekonski B, Saint-Marc P, et al. Activation of extracellular signal-regulated kinases and CREB/ATF-1 mediate the expression of CCAAT/enhancer binding proteins beta and-delta in preadipocytes. Mol Endocrinol. 2001;5:2037-2049.
24. Yang DC, Tsay HJ, Lin SY, Chiou SH, Li MJ, Chang TJ, et al. cAMP/PKA regulates osteogenesis, adipogenesis and ratio of RANKL/OPG mRNA expression in mesenchymal stem cells by suppressing leptin. PLoS One. 2008;3:e1540. doi: 10.1371/journal.pone.0001540 PMID: 18253488
25. Fox KE, Fankell DM, Erickson PF, Majka SM, Crossno JT Jr, Klemm DJ. Depletion of cAMP-response element-binding protein/ATF1 inhibits adipogenic conversion of 3T3-L1 cells ectopically expressing CCAAT/enhancer-binding protein (C/EBP) alpha, C/EBP beta, or PPAR gamma 2. J Biol Chem. 2006;281:40341-40353. PMID: 17071615
26. Vogel CF, Sciullo E, Park S, Liedtke C, Trautwein C, Matsumura F. Dioxin increases C/EBPbeta transcription by activating cAMP/protein kinase A. J Biol Chem. 2004;279:8886-88894. PMID: 14684744
27. Reusch JE, Colton LA, Klemm DJ. CREB activation induces adipogenesis in 3T3-L1 cells. Mol Cell Biol. 2000;2:1008-1020.
28. Zhang BB, Zhou G, Li C. AMPK: an emerging drug target for diabetes and the metabolic syndrome. Cell Metab. 2000;9:407-416.
29. Hardie DG, Carling D. The AMP-activated protein kinase-fuel gauge of the mammalian cell? Eur J Biochem. 1997. 246:259-273. PMID: 9208914
30. Winder WW, Hardie DG. AMP-activated protein kinase, a metabolic master switch: possible roles in type 2 diabetes. Am J Physiol. 1999;277:E1-10. PMID: 10409121
31. Lee JW, Choe SS, Jang H, Kim J, Jeong HW, Jo H, et al. AMPK activation with glabridin ameliorates adiposity and lipid dysregulation in obesity. J Lipid Res. 2012;53:1277-1286. doi: 10.1194/jlr. M022897 PMID: 22493094
32. He Y, Li Y, Zhao T, Wang Y, Sun C. Ursolic acid inhibits adipogenesis in 3T3-L1 adipocytes through LKB1/AMPK pathway. PLoS One. 2013;8:e70135. doi: 10.1371/journal.pone.0070135 PMID: 23922935
33. Moon HS, Chung CS, Lee HG, Kim TG, Choi YJ, Cho CS. Inhibitory effect of (-)-epigallocatechin-3-gallate on lipid accumulation of 3T3-L1 cells. Obesity (Silver Spring). 2007;15:2571-2582. PMID: 18070748
34. Habinowski SA, Witters LA. The effects of AICAR on adipocyte differentiation of 3T3-L1 cells. Biochem Biophys Res Commun. 2001;286:852-856. PMID: 11527376
35. Gao Y, Zhou Y, Xu A, Wu D. Effects of an AMP-activated protein kinase inhibitor, compound C, on adipogenic differentiation of 3T3-L1 cells. Biol Pharm Bull. 2008;31:1716-1722. PMID: 18758065
36. LeBrasseur NK, Kelly M, Tsao TS, Farmer SR, Saha AK, Ruderman NB, et al. Thiazolidinediones can rapidly activate AMP-activated protein kinase in mammalian tissues. Am J Physiol Endocrinol Metab. 2006;291:E175-E181. PMID: 16464908
37. Lee J, Kim D, Choi J, Choi H, Ryu JH, Jeong J, et al. Dehydrodiconiferyl alcohol isolated from Cucurbita moschata shows anti-adipogenic and anti-lipogenic effects in 3T3-L1 cells and primary mouse embryonic fibroblasts. J Biol Chem. 2012;287:8839-8851. doi: 10.1074/jbc. M111.263434 PMID: 22262865
38. Clarke SL, Robinson CE, Gimble JM. CAAT/enhancer binding proteins directly modulate transcription from the peroxisome proliferator-activated receptor gamma 2 promoter. Biochem Biophys Res Commun. 1997;240:99-103. PMID: 9367890